COSMO Pharmaceuticals NV/ NL0011832936 /
| 2024-06-05 5:17:26 PM | Chg. +0.90 | Volume | Bid5:20:00 PM | Ask5:20:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 71.70CHF | +1.27% | 478 Turnover: 34,159.35 |
-Bid Size: - | -Ask Size: - | 1.16 bill.CHF | - | - |
Assets
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 6.4000 | 6 | 22.2000 | 21.7000 | 21.4000 | ||||||
| Intangible Assets | 20.4000 | 22 | 22.2000 | 16.3000 | 10.3000 | ||||||
| Long-Term Investments | 18.2000 | 18.3000 | 66.1000 | 15.5000 | 120.8000 | ||||||
| Fixed Assets | 48.4000 | 49.4000 | 111.9000 | 54.7000 | 154.9000 | ||||||
| Inventories | 1.3000 | 1.8000 | 2.2000 | 2.9000 | 3.3000 | ||||||
| Accounts Receivable | 6.2000 | 6.6000 | 6.2000 | 11.6000 | 4.8000 | ||||||
| Cash and Cash Equivalents | 28.4000 | 13.6000 | 27.3000 | 46.3000 | 34.1000 | ||||||
| Current Assets | 43.4000 | 28.6000 | 40 | 188.3000 | 70.7000 | ||||||
| Total Assets | 91.8000 | 78 | 151.8000 | 243 | 225.6000 | ||||||
Liabilities
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5.6000 | 4.1000 | 4 | 4.2000 | 5.5000 | ||||||
| Long-term debt | 2.2000 | 1.3000 | 11 | 9.8000 | 8.9000 | ||||||
| Liabilities to Banks | 3.5000 | 2.2000 | 12.8000 | 11.8000 | 10.9000 | ||||||
| Provisions | 3.7000 | 2.7000 | 3.4000 | 3 | 3.3000 | ||||||
| Liabilities | 33.5000 | 14.6000 | 27.2000 | 22.8000 | 73.3000 | ||||||
| Share Capital | 3.7000 | 3.7000 | 3.7000 | 3.7000 | 3.7000 | ||||||
| Total Equity | 58.1000 | 63.2000 | 124.4000 | 220.1000 | 152.3000 | ||||||
| Minority Interests | .3000 | .2000 | .2000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 91.8000 | 78 | 151.8000 | 243 | 225.6000 | ||||||
Income Statement
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 32.1000 | 34.3000 | 59.5000 | 56.4000 | 79.6000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 4.8000 | 8.9000 | 26.5000 | 12.9000 | 22.2000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | 4.5000 | 9.1000 | 26.9000 | 71.7000 | 108.9000 | ||||||
| Income Taxes | -.9000 | -1.5000 | -7.6000 | -3 | -35.6000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | 3.6000 | 7.6000 | 19.3000 | 68.7000 | 73.3000 | ||||||
Per Share
Cash Flow
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 7.8000 | 11.3000 | 23 | 8.1000 | 66.4000 | ||||||
| Cash Flow from Investing Activities | -.1000 | -2.8000 | -6 | -3.2000 | -11.5000 | ||||||
| Cash Flow from Financing | 3.4000 | -23.2000 | -3.4000 | 14.1000 | -67.1000 | ||||||
| Decrease / Increase in Cash | 11.2000 | -14.7000 | 13.7000 | 19 | -12.2000 | ||||||
| Employees | 138 | 159 | 160 | 163 | 178 | ||||||
